Literature DB >> 11390006

Diagnostic results before and after introduction of autofluorescence bronchoscopy in patients suspected of having lung cancer detected by sputum cytology in lung cancer mass screening.

M Sato1, A Sakurada, M Sagawa, M Minowa, H Takahashi, T Oyaizu, Y Okada, Y Matsumura, T Tanita, T Kondo.   

Abstract

For the purpose of early detection, we have conducted population-based mass screening for lung cancer by sputum cytology since 1982. Although detection of lung cancer in its early stage is important for a good prognosis, it is often difficult to localize lesions in roentgenographically occult cancer. To clarify the role of autofluorescence bronchoscopy in localizing tumors in patients with roentgenographically occult cancer, we analyzed our diagnostic results. Fifty patients who had been detected by sputum cytology were screened by the light-induced fluorescence endoscope (LIFE)-Lung System from November 1997 to April 1999. We compared the results according to the screening methods: conventional bronchoscopy alone versus LIFE with conventional white-light bronchoscopy (November 1997 to April 1999). Twenty-eight cancerous lesions and 39 borderline lesions were detected by LIFE. Of the 39 borderline lesions, nine were detected only by LIFE. Multicentric lesions including cancer or dysplasia were also detected in 21 of the 50 patients by LIFE. The sensitivity by white-light bronchoscopy alone was 85.3%, whereas that of the LIFE-Lung System with white-light bronchoscopy was 94.1% (P=0.078). There were no cancerous lesions in the area observed as normal by LIFE. We also compared the diagnostic results of two localization methods: brushing of all bronchi (September 1986 to December 1990) and the LIFE-Lung System (November 1997 to April 1999). Although this was a historical comparison, the number of detected borderline lesions increased, which led to a high detection rate in patients with suspected-positive sputum (P=0.0006) by the LIFE-Lung System. In conclusion, the LIFE-Lung System is a safe and non-invasive system for detecting small intraepithelial lesions of the tracheobronchial tree. Autofluorescence bronchoscopy is more efficacious for localizing intraepithelial lesions and places fewer burdens on the patient than brushing of all bronchi.

Entities:  

Mesh:

Year:  2001        PMID: 11390006     DOI: 10.1016/s0169-5002(00)00229-4

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  10 in total

Review 1.  Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities.

Authors:  A K Banerjee; P H Rabbitts; J George
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

Review 2.  Early central airways lung cancer.

Authors:  Chiaki Endo; Akira Sakurada; Takashi Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-07-19

3.  White light, autofluorescence and narrow-band imaging bronchoscopy for diagnosing airway pre-cancerous and early cancer lesions: a systematic review and meta-analysis.

Authors:  Jianrong Zhang; Jieyu Wu; Yujing Yang; Hua Liao; Zhiheng Xu; Lindsey Tristine Hamblin; Long Jiang; Lieven Depypere; Keng Leong Ang; Jiaxi He; Ziyan Liang; Jun Huang; Jingpei Li; Qihua He; Wenhua Liang; Jianxing He
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

4.  Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomised controlled multicentre trial.

Authors:  K Häussinger; H Becker; F Stanzel; A Kreuzer; B Schmidt; J Strausz; S Cavaliere; F Herth; M Kohlhäufl; K-M Müller; R-M Huber; U Pichlmeier; Ch T Bolliger
Journal:  Thorax       Date:  2005-06       Impact factor: 9.139

5.  Detection and minimally invasive treatment of early squamous lung cancer.

Authors:  Johannes M A Daniels; Thomas G Sutedja
Journal:  Ther Adv Med Oncol       Date:  2013-07       Impact factor: 8.168

6.  Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment.

Authors:  Gregory Loewen; Nachimuthu Natarajan; Dongfeng Tan; Enriqueta Nava; Donald Klippenstein; Martin Mahoney; Michael Cummings; Mary Reid
Journal:  Thorax       Date:  2006-11-13       Impact factor: 9.139

7.  Lung cancer detection by native fluorescence spectra of body fluids--a preliminary study.

Authors:  Mohammad Al-Salhi; Vadivel Masilamani; Trinka Vijmasi; Hicham Al-Nachawati; A P VijayaRaghavan
Journal:  J Fluoresc       Date:  2010-10-19       Impact factor: 2.217

8.  Detection and localization of intraepithelial neoplasia and invasive carcinoma using fluorescence-reflectance bronchoscopy: an international, multicenter clinical trial.

Authors:  Eric Edell; Stephen Lam; Harvey Pass; York E Miller; Thomas Sutedja; Timothy Kennedy; Gregory Loewen; Robert L Keith; Adi Gazdar
Journal:  J Thorac Oncol       Date:  2009-01       Impact factor: 15.609

9.  Optical detection of preneoplastic lesions of the central airways.

Authors:  C van der Leest; A Amelink; R J van Klaveren; H C Hoogsteden; H J C M Sterenborg; J G J V Aerts
Journal:  ISRN Oncol       Date:  2012-03-22

10.  Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine.

Authors:  György Marko-Varga; Akos Végvári; Melinda Rezeli; Kaiu Prikk; Peeter Ross; Magnus Dahlbäck; Goutham Edula; Ruth Sepper; Thomas E Fehniger
Journal:  Clin Transl Med       Date:  2012-05-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.